"bms" の関連情報検索結果
News
Q&A
Shopping
Auction
Rakuten
amazonBristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026 - Bristol ...
Bristol Myers Squibb Launches “Won't Lose” Media Campaign Ahead of FIFA World Cup 2026 Bristol Myers Squibb
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception. - The New York Times
American Factories Lag in Adopting A.I. This Drugmaker Is an Exception. The New York Times
Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger - Fierce ...
Bristol Myers Squibb ties science to soccer in World Cup campaign voiced by Ali Krieger Fierce Pharma
Cytokinetics gets jump on BMS as Myqorzo succeeds in non-obstructive HCM trial - FirstWord Pharma
Cytokinetics gets jump on BMS as Myqorzo succeeds in non-obstructive HCM trial FirstWord Pharma
BMS Gets EU Approval for Sotyktu for Treatment of Active Psoriatic Arthritis - Contract Pharma
BMS Gets EU Approval for Sotyktu for Treatment of Active Psoriatic Arthritis Contract Pharma
EC approves new use for BMS’ Sotyktu - The Pharma Letter
EC approves new use for BMS’ Sotyktu The Pharma Letter
Foundation Medicine Expands Bristol Myers Squibb Deal to Develop MTAP Biomarker Test - Clinical L...
Foundation Medicine Expands Bristol Myers Squibb Deal to Develop MTAP Biomarker Test Clinical Lab Products
Bristol Myers Squibb files WARN notice for 206 jobs - ROI-NJ
BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut - BioSpace
BMS makes a Beeline, bringing 5 assets to biotech’s $300M precision immunology debut BioSpace
BMS, BLMS track & field compete at Larry Young Invite - Peak of Ohio
BMS, BLMS track & field compete at Larry Young Invite Peak of Ohio
Bristol Myers Squibb Expands Decade-Long Standing in the Gaap Program to Address Multiple Myeloma...
Bristol Myers Squibb Expands Decade-Long Standing in the Gaap Program to Address Multiple Myeloma Disparities geneonline.com
BMS, SLS Golf Compete in Four-Way - WRBI Radio
BMS, SLS Golf Compete in Four-Way WRBI Radio
CRC approval for BMS's Krazati in doubt after confirmatory study miss - FirstWord Pharma
CRC approval for BMS's Krazati in doubt after confirmatory study miss FirstWord Pharma
BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfol...
BMS 'well prepared' for Camzyos competition as revenue from new products overtakes legacy portfolio Fierce Pharma
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout - BioSpace
BMS positions Cobenfy as safer alternative ahead of pivotal Alzheimer’s psychosis readout BioSpace
Champions in Care - Bristol Myers Squibb
Champions in Care Bristol Myers Squibb
Biopharma bites: BMS axes more staff, Biogen's mAb deal, plus CAR-T data from Kyverna - FirstWord...
Biopharma bites: BMS axes more staff, Biogen's mAb deal, plus CAR-T data from Kyverna FirstWord Pharma
Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial - Fierce Pharma
Cytokinetics' Myqorzo succeeds in landmark cardiomyopathy trial Fierce Pharma
The Time Back campaign honors the most precious gift oncologists provide in cancer care: time - B...
The Time Back campaign honors the most precious gift oncologists provide in cancer care: time Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy - Bristol Myers Squibb
Science Firsthand: Translating the promise of cell therapy Bristol Myers Squibb
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi - Bri...
Bristol Myers Squibb Teams Up with Kasey Keller to Share His Lymphoma Journey with Breyanzi Bristol Myers Squibb
BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3 - Fierce Biotech
BMS builds momentum for CELMoD drug after improving myeloma PFS in phase 3 Fierce Biotech
Science Firsthand: Making the leap to intentionally designed degraders - Bristol Myers Squibb
Science Firsthand: Making the leap to intentionally designed degraders Bristol Myers Squibb
Redefining biologics & cell therapy manufacturing at Devens - Bristol Myers Squibb
Redefining biologics & cell therapy manufacturing at Devens Bristol Myers Squibb
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy...
Bristol Myers Squibb’s Breyanzi Approved by the U.S. FDA as the First and Only CAR T Cell Therapy for Adults with Relapsed or Refractory Marginal Zone Lymphoma (MZL) Bristol Myers Squibb
Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities - WJHL
Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities WJHL
Yamaha Banshee Jet Kit Carburettor For Znen Lance BMS Jonway Vento - aviglianonews.it
Yamaha Banshee Jet Kit Carburettor For Znen Lance BMS Jonway Vento aviglianonews.it
Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities - WJHL
Motor officers from 6 states at BMS for competition to benefit Speedway Children’s Charities WJHL
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments - BioSpace
BMS Bets $850M on Janux’s Tumor-Activated Drugs, Deepening Cancer Investments BioSpace
Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? - Labiotech.eu
Can Bristol Myers Squibb’s pipeline strategy offset a major patent cliff? Labiotech.eu
Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS - Fierce B...
Bain-backed Beeline Medicines buzzes out of stealth with $300M and 5 programs from BMS Fierce Biotech
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B - Fierce ...
Harbour BioMed docks with BMS in antibody discovery, development deal worth up to $1.1B Fierce Biotech
JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff - Clinical Trials Arena
JPM26: BMS places confidence in core pipeline to weather 2030 patent cliff Clinical Trials Arena
Empowering patients with clarity & confidence through UPL program - Bristol Myers Squibb
Empowering patients with clarity & confidence through UPL program Bristol Myers Squibb
Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis - Fie...
Bristol Myers Squibb taps Microsoft's AI detection network for speedy lung cancer diagnosis Fierce Biotech
Building a healthier future together: Strengthening cancer care across Africa through partnership...
Building a healthier future together: Strengthening cancer care across Africa through partnership Bristol Myers Squibb
Honoring oncologists through the Time Back campaign - Bristol Myers Squibb
Honoring oncologists through the Time Back campaign Bristol Myers Squibb
BMS and Oxford BioTherapeutics join forces in TCE discovery pact - Pharmaceutical Technology
BMS and Oxford BioTherapeutics join forces in TCE discovery pact Pharmaceutical Technology
A bold blueprint for transforming lupus outcomes - Bristol Myers Squibb
A bold blueprint for transforming lupus outcomes Bristol Myers Squibb
Driving patient-centric care through global patient outreach - Bristol Myers Squibb
Driving patient-centric care through global patient outreach Bristol Myers Squibb
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line - BioSpace
BMS Deepens ALS Alliance With Insitro, Puts $2B+ On the Line BioSpace
This pharma giant just announced hundreds more layoffs in N.J. - NJ.com
This pharma giant just announced hundreds more layoffs in N.J. NJ.com
Cytokinetics stock adds more than $1 billion of valuation in a single day — Here's why - The Busi...
Cytokinetics stock adds more than $1 billion of valuation in a single day — Here's why The Business Journals
Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countri...
Bringing life-saving medicines to more patients: Our commitment to low- and middle-income countries Bristol Myers Squibb
Nurse practitioners impact patient care and foster collaboration - Bristol Myers Squibb
Nurse practitioners impact patient care and foster collaboration Bristol Myers Squibb
Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial - Fierce ...
Bristol Myers' $800M ADC hits primary survival endpoints in phase 3 breast cancer trial Fierce Biotech
Protein homeostasis 101: A Q&A with Mark Rolfe - Bristol Myers Squibb
Protein homeostasis 101: A Q&A with Mark Rolfe Bristol Myers Squibb
BMS snags top neuro researcher from Eisai—Chutes & Ladders - Fierce Biotech
BMS snags top neuro researcher from Eisai—Chutes & Ladders Fierce Biotech
With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm - Fierc...
With declining sales of legacy meds, BMS leans on new growth drivers to weather the storm Fierce Pharma
BMS pens $850M solid tumor pact with T-cell engager biotech Janux - Fierce Biotech
BMS pens $850M solid tumor pact with T-cell engager biotech Janux Fierce Biotech
BMS Beats Again Despite Eliquis and Cobenfy Disappointments - BioSpace
BMS Beats Again Despite Eliquis and Cobenfy Disappointments BioSpace
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking ...
Q&A with Robert Plenge: What is Bristol Myers Squibb’s research strategy and where are we taking it? Bristol Myers Squibb
Bristol Myers Squibb and Bain Capital Create New Company Dedicated to Developing Innovative Immun...
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree - Fierce Pharma
BMS' Cobenfy TV ad is latest target of FDA untitled letter spree Fierce Pharma
Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA - Fierc...
Racing BMS and J&J, Bayer links asundexian to 26% stroke reduction to unblock path to FDA Fierce Biotech
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover - BioSpace
BMS Makes $1.5B Cell Therapy Play With Orbital Takeover BioSpace
"Too many patients in rural America face barriers to cardiovascular care — barriers that - Bristo...
"Too many patients in rural America face barriers to cardiovascular care — barriers that Bristol Myers Squibb
Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more - FirstWo...
Biopharma bites: Layoffs at BMS, Generate's IPO plans, Fortress's voucher sale…and more FirstWord Pharma
Science Firsthand: The renaissance of neuroscience R&D - Bristol Myers Squibb
Science Firsthand: The renaissance of neuroscience R&D Bristol Myers Squibb
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients - ...
BMS plots another DTC platform, this one offering Sotyktu at 86% discount to cash-pay patients Fierce Pharma
Crystallizing exponential possibilities in protein degradation - Bristol Myers Squibb
Crystallizing exponential possibilities in protein degradation Bristol Myers Squibb
BMS Teacher of the Year arrested on child sex abuse charges - KATC
BMS Teacher of the Year arrested on child sex abuse charges KATC
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis - F...
With site 'irregularities,' Bristol Myers delays key Cobenfy readout in Alzheimer's psychosis Fierce Pharma
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review - Ad Age
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review Ad Age
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy - BioSpace
JPM26: BMS’s Early-Stage Bets Are Happening Now, Amid Pharma’s Late-Stage Frenzy BioSpace
Merck & Co., BMS to lay off over 300 staffers in New Jersey - FirstWord Pharma
Merck & Co., BMS to lay off over 300 staffers in New Jersey FirstWord Pharma
Bristol Myers Squibb honoured with the prestigious Prix Galien Award - Bristol Myers Squibb
Bristol Myers Squibb honoured with the prestigious Prix Galien Award Bristol Myers Squibb
New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role - Purd...
New BMS Department Head Makes Enthusiastic Return to Purdue to Take on New Leadership Role Purdue University College of Veterinary Medicine
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future -...
BMS and Takeda dive into AI data pool, joining peers in collaborative push to unfold the future Fierce Biotech
BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe - JUVE Patent
BMS and Johnson & Johnson battle over novel CAR-T cell therapy in Europe JUVE Patent
Harnessing the Potential of Anti-Cancer Modalities - Bristol Myers Squibb
Harnessing the Potential of Anti-Cancer Modalities Bristol Myers Squibb
Veterans redefining manufacturing leadership in pharma - Bristol Myers Squibb
Veterans redefining manufacturing leadership in pharma Bristol Myers Squibb
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future - Harvard Business Review
How Bristol Myers Squibb Transformed Working Capital to Fund Its Future Harvard Business Review
BMS sells controlling stake in historic US-China pharmaceutical joint venture - Fierce Pharma
BMS sells controlling stake in historic US-China pharmaceutical joint venture Fierce Pharma
A global journey through BMS’ R&D hubs - Bristol Myers Squibb
A global journey through BMS’ R&D hubs Bristol Myers Squibb
Karen Costello appointed General Manager of Bristol Myers Squibb Benelux - Bristol Myers Squibb
Karen Costello appointed General Manager of Bristol Myers Squibb Benelux Bristol Myers Squibb
New RayzeBio hub accelerates next-gen cancer therapies - Bristol Myers Squibb
New RayzeBio hub accelerates next-gen cancer therapies Bristol Myers Squibb
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia - Fier...
BMS removes 2 clinical programs from pipeline, one from Mirati and another from Exscientia Fierce Biotech
An intelligent controlling in electric vehicle system with integrated DBS and BMS for sustainable...
BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes - Fierce Biotech
BMS and J&J's blood thinner flunks phase 3, denting big blockbuster hopes Fierce Biotech
Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal - Fierce Pharma
Rovi acquires BMS facility in Phoenix and strikes $250M manufacturing deal Fierce Pharma
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage tr...
ESMO: BMS looks to 'stay ahead of the competition' with ADC's 55% response rate in early-stage trial Fierce Biotech
Bristol Myers Squibb Commits to Veeva Vault CRM - Veeva
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study - BioSpace
BMS Delays Cobenfy Alzheimer’s Psychosis Data After ‘Irregularities’ in Phase III Study BioSpace
Chris Shibutani, MD - Bristol Myers Squibb
Chris Shibutani, MD Bristol Myers Squibb
Workforce Planner: Manage people and projects in BMS - Kaseya
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates...
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates BioSpace
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma - Fierce Biotech
Bristol Myers midtrial endpoint addition secures phase 3 win in multiple myeloma Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence - Fierce Biotech
BMS inks $1.5B in vivo CAR-T buyout to pull Orbital into its sphere of influence Fierce Biotech
Protein degradation: Recycling in action - Bristol Myers Squibb
Protein degradation: Recycling in action Bristol Myers Squibb
Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless - BioSpace
Novo, BMS Layoffs Hit New Jersey Hard With More Than 500 Left Jobless BioSpace
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy ...
In UK, Big Pharma pressure campaign rolls on as Bristol Myers plans US-level pricing for Cobenfy Fierce Pharma
Bristol Myers Squibb discloses 247 more layoffs in NJ (updated) - NJBIZ
Bristol Myers Squibb discloses 247 more layoffs in NJ (updated) NJBIZ
Trials to Transformation: How challenges can lead to triumphs - Bristol Myers Squibb
Trials to Transformation: How challenges can lead to triumphs Bristol Myers Squibb
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future - Fi...
BMS' hyped schizophrenia med Cobenfy delivers so-so launch year as execs map plan for future Fierce Pharma
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set pha...
BioNTech, BMS tout first global data for PD-L1xVEGF bispecific in small cell lung cancer, set phase 3 dose Fierce Biotech
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles - Fierce Pharma
In New Jersey, Novo Nordisk cuts 263 workers while BMS slashes 282 roles Fierce Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US - FirstWord Pharma
BMS, Pfizer launch direct-to-consumer push for Eliquis in the US FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO - FirstWord Pharma
BMS shuffles R&D leadership, bringing in AstraZeneca exec as new CMO FirstWord Pharma
Bristol Myers Squibb Cutting 206 More Jobs - New Jersey Business Magazine
Bristol Myers Squibb Cutting 206 More Jobs New Jersey Business Magazine